Market cap
$104 Mln
Market cap
$104 Mln
Revenue (TTM)
$242 Mln
P/E Ratio
--
P/B Ratio
0.4
Div. Yield
0 %
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
$0 Mln
ROE
-0.4 %
ROCE
-- %
Industry P/E
--
EV/EBITDA
46.7
Debt to Equity
0.6
Book Value
$2.6
EPS
$-1.3
Face value
--
Shares outstanding
105,456,979
CFO
$146.79 Mln
EBITDA
$176.13 Mln
Net Profit
$-409.95 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Definitive Healthcare Corp (DH)
| -67.4 | -13.4 | -54.4 | -67.1 | -54.4 | -- | -- |
|
BSE Sensex
| -9.0 | 5.0 | -8.1 | -4.3 | 7.6 | 9.8 | 11.9 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
|---|---|---|---|---|
|
Definitive Healthcare Corp (DH)
| -30.2 | -58.4 | -9.6 | -59.8 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Definitive Healthcare Corp (DH)
|
0.9 | 104.0 | 241.5 | -138.9 | -82.0 | -38.3 | -- | 0.4 |
| 173.3 | 6,120.6 | 995.3 | 152.0 | 17.4 | 31.4 | 41.1 | 13.0 | |
| 6.6 | 12,015.8 | 3.0 | -816.0 | -29,333.3 | -40.6 | -- | 5.6 | |
| 24.2 | 7,210.4 | 731.4 | -38.8 | 1.5 | -2.6 | -- | 3.6 | |
| 58.7 | 5,489.7 | 1,364.9 | 243.7 | 11.6 | 9.3 | 22.8 | 2.1 | |
| 25.3 | 5,949.3 | 2,521.0 | 508.4 | 28.7 | -39.9 | 13.4 | 29.8 | |
| 82.0 | 6,961.0 | 1,313.4 | 215.2 | 24.6 | 10.2 | 33.5 | 3.3 | |
| 36.5 | 6,049.6 | 1,700.2 | 340.8 | 11.4 | 52.3 | 19.6 | 8.6 | |
| 12.1 | 6,805.1 | 1,071.4 | -270.1 | -28.1 | -42.9 | -- | 1.0 | |
| 27.5 | 11,837.6 | 1,849.7 | -402.8 | -20.4 | -12.5 | -- | 3.7 |
Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers... and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution. The company's platform consists of various functional areas, such as sales, marketing, clinical research and product development, strategy, talent acquisition, and physician network management. It serves biopharmaceutical and medical device companies, healthcare information technology companies, and healthcare providers; and other diversified companies comprising staffing and commercial real estate firms, financial institutions, marketing and advertising agencies.Definitive Healthcare Corp. was founded in 2011 and is headquartered in Framingham, Massachusetts. Address: 492 Old Connecticut Path, Framingham, MA, United States, 01701 Read more
Founder, Executive Chairman & Interim CEO
Mr. Jason Ronald Krantz
Founder, Executive Chairman & Interim CEO
Mr. Jason Ronald Krantz
Headquarters
Framingham, MA
Website
The share price of Definitive Healthcare Corp (DH) is $0.94 (NASDAQ) as of 05-May-2026 13:37 EDT. Definitive Healthcare Corp (DH) has given a return of -54.45% in the last 3 years.
Since, TTM earnings of Definitive Healthcare Corp (DH) is negative, P/E ratio is not available.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
-2.21
|
1.09
|
|
2024
|
-1.16
|
1.08
|
|
2023
|
-5.55
|
1.30
|
|
2022
|
-153.70
|
1.17
|
|
2021
|
-48.44
|
2.89
|
The 52-week high and low of Definitive Healthcare Corp (DH) are Rs 4.70 and Rs 0.90 as of 06-May-2026.
Definitive Healthcare Corp (DH) has a market capitalisation of $ 104 Mln as on 04-May-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Definitive Healthcare Corp (DH), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.